Hui Kang

机构：Guangzhou First People's Hospital, Guangzhou Medical University · ORCID：0009-0008-7801-8776

发表论文 27 篇 · 总被引 88 次 · h-index 5

代表论文

• RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4 (2023 · Oncogene · 被引 39)
• ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway (2024 · Experimental Hematology and Oncology · 被引 12)
• The Correlation Between Serum Copper and Non-alcoholic Fatty Liver Disease in American Adults: an Analysis Based on NHANES 2011 to 2016 (2024 · Biological Trace Element Research · 被引 11)
• Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis (2023 · Journal of Translational Medicine · 被引 10)
• Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway (2024 · Molecular Cancer Research · 被引 6)
• Use of lasers in gastrointestinal endoscopy: a review of the literature (2023 · Lasers in Medical Science · 被引 3)